» Articles » PMID: 2579980

Immunohistochemical Demonstration of Differential Substance P-, Met-enkephalin-, and Glutamic-acid-decarboxylase-containing Cell Body and Axon Distributions in the Corpus Striatum of the Cat

Overview
Journal J Comp Neurol
Specialty Neurology
Date 1985 Feb 22
PMID 2579980
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The immunohistochemical localization of neuronal cell bodies and axons reactive for substance P (SP) and methionine-enkephalin (ME) was investigated in the corpus striatum of the adult cat brain and compared with that of glutamate decarboxylase (GAD), synthetic enzyme for gamma-aminobutyric acid. Striatal cell bodies reactive for ME could be identified only in colchicine treated cats, are medium size, ovoid striatal cells, and are found in large numbers in a more or less even distribution throughout the caudate nucleus, putamen, and nucleus accumbens. The striatal region most densely occupied by ME-immunoreactive cells is the ventral and central part of the caudate head. Modest numbers of larger ME-reactive neurons are dispersed throughout the entopeduncular nucleus and the pars reticulata of the substantia nigra. Striatal cells of medium size reactive for SP could be identified, with or without colchicine, in largest numbers in the medial half of the caudal three-fourths of the putamen and in clusters of irregular size and shape in the head of the caudate nucleus. Cells reactive for SP are also common in layer II and the islands of Calleja of the olfactory tubercle. We could not reliably visualize GAD-positive cell bodies in the striatum, even with colchicine treatment; however, they could be seen readily in all pallidal structures such as the globus pallidus, ventral pallidum, entopeduncular nucleus, and substantia nigra. Axons reactive for ME are found mainly in the globus pallidus where they form a dense and even network throughout the nucleus. The globus pallidus is almost devoid of SP reactivity except near its extreme caudal pole. Conversely, SP-immunoreactive axons form dense meshworks in the entopeduncular nucleus and substantia nigra where ME immunoreactivity is minimal. Fewer, but still ample numbers, of SP-reactive axons are present also in the ventral tegmental and retrorubral areas of the midbrain tegmentum and in the ventral pallidum of the basal forebrain, but only sparse ME-reactive axons are present in these areas. This differential distribution of SP- and ME-containing axons in the pallidal and nigral structures stands in contrast to the relatively homogeneous and dense distribution of GAD-containing axons throughout the dorsal and ventral pallidum, entopeduncular nucleus, and substantia nigra.(ABSTRACT TRUNCATED AT 400 WORDS)

Citing Articles

Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: An historical perspective.

Gerfen C Front Synaptic Neurosci. 2023; 14:1002960.

PMID: 36741471 PMC: 9892636. DOI: 10.3389/fnsyn.2022.1002960.


Three divisions of the mouse caudal striatum differ in the proportions of dopamine D1 and D2 receptor-expressing cells, distribution of dopaminergic axons, and composition of cholinergic and GABAergic interneurons.

Miyamoto Y, Nagayoshi I, Nishi A, Fukuda T Brain Struct Funct. 2019; 224(8):2703-2716.

PMID: 31375982 PMC: 6778543. DOI: 10.1007/s00429-019-01928-3.


Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders.

Plotkin J, Goldberg J Neuroscientist. 2018; 25(4):359-379.

PMID: 30379121 PMC: 6529282. DOI: 10.1177/1073858418807887.


Lateral preoptic and ventral pallidal roles in locomotion and other movements.

Subramanian S, Reichard R, Stevenson H, Schwartz Z, Parsley K, Zahm D Brain Struct Funct. 2018; 223(6):2907-2924.

PMID: 29700637 PMC: 5997555. DOI: 10.1007/s00429-018-1669-2.


Activation of Dopamine D1-D2 Receptor Complex Attenuates Cocaine Reward and Reinstatement of Cocaine-Seeking through Inhibition of DARPP-32, ERK, and ΔFosB.

Hasbi A, Perreault M, Shen M, Fan T, Nguyen T, Alijaniaram M Front Pharmacol. 2018; 8:924.

PMID: 29354053 PMC: 5758537. DOI: 10.3389/fphar.2017.00924.